Lazivudine
№ 60
Pharmacotherapeutic group
Active ingredient
Pharmaceutical form
Film-coated tablets
ATC code
J05AR01
RX/OTC
RX
Registration certificate
UA/15690/01/01
General properties
Pharmacotherapeutic group
Antiviral agents for systemic use. Antiviral means of direct action. Antiviral drugs for the treatment of HIV infection, combination.
Therapeutic indications
- Treatment of HIV infection.
Contraindications
Hypersensitivity to lamivudine, zidovudine or to any of the components of the drug. The level of neutrophils is below 0.75 x 109 / L or the hemoglobin level is below 7.5 g / dL, or 4.65 li mmol / l (see section "Application features").
Pharmaceutical characteristics
Main physicochemical properties
The tablets are capsular, oval, covered with a shell, white or almost white, with upper and lower convex surfaces.
Shelf life
2 years.
Storage
Store at a temperature not exceeding 30 °C. Keep out of the reach of children.
Manufacturer
PJSC "Technolog".
Location
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.
